0
Signin
countryflagUS

18889881171

AAPL 190.415 0.3663% MSFT 422.65 -0.1016% GOOG 175.36 0.8512% GOOGL 174.14 0.9449% AMZN 185.71 -0.1505% NVDA 943.46 -0.3001% META 473.555 -1.6582% TSLA 174.87 0.5058% TSM 154.06 -0.977% LLY 776.1758 -1.3779% V 280.145 -0.2972% AVGO 1436.4972 0.0228% JPM 204.205 1.0366% UNH 522.225 0.9033% NVO 133.03 -1.2105% WMT 63.485 6.109% LVMUY 170.79 -0.2511% XOM 117.87 -0.5988% LVMHF 855.728 -0.1473% MA 461.6867 0.805%

Redwood Scientific Technologies Inc

Healthcare US RSCI

1.1595USD
0.04(3.99%)

Last update at 2024-05-16T16:33:00Z

Day Range

1.141.17
LowHigh

52 Week Range

0.00020.42
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2020-12-31 2016-12-31 2015-12-31 2014-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2020-12-31 2016-12-31 2015-12-31 2014-12-31
Income before tax -0.14371M -0.04930M 0.00126M -0.00611M -0.01868M
Minority interest - - - - -
Net income -0.14371M -0.04930M 0.00126M -0.00611M -0.02055M
Selling general administrative 0.14M 0.04M - - 0.02M
Selling and marketing expenses - - - - -
Gross profit - - 0.00490M 0.00114M 0.00000M
Reconciled depreciation 0.00000M - - - -
Ebit - - 0.00126M -0.00611M -0.01843M
Ebitda - - - - -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -0.14371M -0.04914M 0.00126M -0.00611M -0.01843M
Other operating expenses - - - - -
Interest expense - - 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - 0.00000M 0.00000M 0.00000M
Total revenue 0.00000M 0.00000M 0.00490M 0.00114M 0.00000M
Total operating expenses 0.14M 0.05M 0.00000M 0.00000M 0.00000M
Cost of revenue - - 0.00000M 0.00000M 0.00000M
Total other income expense net - -0.00016M - - -
Discontinued operations - - - - -
Net income from continuing ops -0.14371M -0.04930M 0.00126M -0.00611M -0.01868M
Net income applicable to common shares - - 0.00126M -0.00611M -0.02055M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2016-12-31 2015-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2016-12-31 2015-12-31
Total assets 0.00000M 0.00000M 0.00000M 0.01M 0.01M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - 0.00025M
Total liab 0.14M 0.00000M -0.00000M 0.72M 0.70M
Total stockholder equity -0.14371M 0.00000M 0.00000M -0.70990M -0.68342M
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock - - - - -
Capital stock 0.18M 0.18M 0.18M - -
Retained earnings -5.27542M -5.13171M -5.13171M - -
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash - - - 0.00129M 0.00084M
Cash and equivalents - - - - -
Total current liabilities 0.14M 0.00000M 0.00000M 0.00364M 0.00096M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - - - 0.01M 0.01M
Total current assets 0.00000M 0.00000M 0.00000M 0.00349M 0.00223M
Long term investments - - - - -
Net tangible assets - - - -0.70990M -0.68342M
Short term investments - - - - -
Net receivables 0.00000M 0.00000M - 0.00220M 0.00114M
Long term debt - - - 0.72M 0.70M
Inventory - - - - -
Accounts payable - - - 0.00364M 0.00096M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.00000M 0.00000M 0.00000M - -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2020-12-31 2016-12-31 2015-12-31 2014-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2020-12-31 2016-12-31 2015-12-31 2014-12-31
Investments 0.00000M - - - -
Change to liabilities - - - - -
Total cashflows from investing activities - - - - -
Net borrowings - - - - -
Total cash from financing activities - - - - -
Change to operating activities - - - - -
Net income -0.14371M -0.04930M 0.00126M -0.00611M -0.02055M
Change in cash 0.00000M -0.04930M 0.00036M 0.00035M 0.00002M
Begin period cash flow 0.00000M - - - -
End period cash flow 0.00000M -0.04930M - - -
Total cash from operating activities 0.00000M -0.04930M 0.00126M -0.00611M -0.00611M
Issuance of capital stock - - - - -
Depreciation 0.00000M - - - -
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.14M - - - -
Stock based compensation 0.00000M - - - -
Other non cash items - - - - -
Free cash flow 0.00000M -0.04930M - - -

Fundamentals

  • Previous Close 1.11
  • Market Cap22.68M
  • Volume900
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.69498M
  • Revenue TTM0.26M
  • Revenue Per Share TTM3.21
  • Gross Profit TTM 0.13M
  • Diluted EPS TTM-12.12

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
RSCI
Redwood Scientific Technologies Inc		 0.04 3.99% 1.16 - - 87.34 - -157.8429
ZTS
Zoetis Inc		 0.68 0.39% 173.96 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.51 1.41% 36.61 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 6.91 3.93% 182.50 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.045 0.34% 13.35 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology. The company is based in Claremont, California.

Redwood Scientific Technologies Inc

250 West 1st Street, Claremont, CA, United States, 91711

Key Executives

Name Title Year Born
Mr. Benjamin M. Lefrancois Chief Exec. Officer, Pres, Chief Financial Officer and Director 1969
Mr. Larry McKenna Chief Technology Officer 1965

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).